ÂÜÀòÂÒÂ×

Mark Weinstein is the current Director at Strategikon Pharma, and they have held this position since December of 2018. Prior to their current role, Mark served as the President & CEO of BioClinica, Inc. from June of 1997 to January of 2015. Mark then became a Member of the Board of Directors for CRO Analytics from January of 2015 to December of 2018. Mark's career began at Medical Economics (ThomsonReuters Healthcare), where they served as the President of the International Group from May of 1991 to May of 1997.

Mark Weinstein has a MBA from William & Mary – Raymond A. Mason School of Business and a BS in Economics from the University of Virginia.